MedTrace Logo

Statin Therapy Results in the Real World Practice in the Czech Republic

NCT01055977 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3253

Last updated 2011-08-30

No results posted yet for this study

Summary

Statins are the first choice treatment of dyslipidemia, a major contributor to cardiovascular diseases. Statins also have enough evidence to demonstrate decrease of morbidity and mortality from cardiovascular diseases. Even though statin therapy is effective treatment of dyslipidaemia not all patients reach the goal levels.

The aim of the study is to estimate proportion of patients who achieved the therapeutic goal (LDL-C. total cholesterol, HDL-C and triglycerides levels) after at least one year of a statin therapy.

Conditions

  • Dyslipidaemia

Sponsors & Collaborators

Principal Investigators

  • Ales Kminek · AstraZeneca

  • Jaromir Hradec · General faculty hospital Prague

  • Jan Bultas · Faculty hospital Kralovske Vinohrady Prague

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01055977 on ClinicalTrials.gov